Nanomedicine News

RSS

LamdaGen Opens Wholly-Owned Subsidiary, LamdaGen Nanotechnology Taiwan

LamdaGen Corporation, a nano-technology platform company that provides LSPR based plasmonic sensors and systems for In Vitro Diagnostics (IVD), announced the opening of a wholly-owned subsidiary, LamdaGen Nanotechnology Taiwan Co., LTD. (LamdaGen Taiwan).

19 Mar 2015

Global Forecast Report on Nanotechnology in Medical Devices Market

According to a new market research report "Nanotechnology in Medical Devices Market by Product (Biochip, Implant Materials, Medical Textiles, Wound Dressing, Cardiac Rhythm Management Devices, Hearing Aid), Application (Therapeutic, Diagnostic, Research) - Global Forecast to 2019", published by MarketsandMarkets, the Nanotechnology in Medical Devices Market is was valued at around $5 Billion in 2014 and expected to reach around $8.5 Billion by 2019 with a CAGR of around 11-12% during the forecast period 2014 - 2019.

19 Mar 2015

UTHSC CTRC Begins Nanotherapy Brain Cancer Trial in Humans

David Williams is the first human being ever to have a new radiation treatment implanted in the center of his brain tumor.

18 Mar 2015

Nanotherapeutics Secures $28.5 Million Debt Financing from White Oak Global Advisors

Nanotherapeutics, Inc., an integrated biopharmaceutical company with a focus on advanced development and manufacturing, announced today that it has secured a $28.5 million debt financing from White Oak Global Advisors, LLC. The funds will support the completion of the Company’s 180,000 sq. ft. flexible biologics manufacturing facility located in Alachua.

18 Mar 2015

Nanotechnologies in Drug Delivery Congress to be Held 27 - 28 April 2015 in London

Diagnosis and Drug Delivery for diseases like cancer, cardiovascular and genetic ailments have always been a concern. In recent years, however, new strides and developments in the Nano-Medicine Market have facilitated more effective diagnosis and drug delivery for diseases.

18 Mar 2015

Immune Licenses Yissum's Patents to Facilitate Development of AmiKet’s Topical Nanoparticle Formulation

Immune Pharmaceuticals Inc. ("Immune", the "Company") announced today that it has entered into a binding memorandum of understanding with Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, to license certain of Yissum's patents in order to facilitate the development of a topical nanoparticle formulation of Immune's neuropathic pain drug, AmiKet™.

17 Mar 2015

N1 Technologies Seeks Patent for Nano Engineered TungstenGlass

The directors and management of N1 Technologies Inc. have just filed a Patent for a revolutionary nano engineered super glass called "TungstenGlass." The company has developed a next generation nano based glass that features high impact and torsion resistance along with enhanced electrical properties.

17 Mar 2015

Disposable Molecular Ruler Helps Determine Length of Bacteria’s Nanoscopic Needle

When a salmonella bacterium attacks a cell, it uses a nanoscopic needle to inject it with proteins to aid the infection. If the needle is too short, the cell won’t be infected. Too long, and the needle breaks. Now, University of Utah biologists report how a disposable molecular ruler or tape measure determines the length of the bacterial needle so it is just right.

17 Mar 2015

New Research into Using Magnetic Nanoparticles in Localised Brain Tissue Stimulation

MIT researchers have created a technique to stimulate brain tissue using injected magnetic nanoparticles and external magnetic fields.

From Massachusetts Institute of Technology 13 Mar 2015

Light and Targeted Gold Nanoparticles Can Be Used to Activate Non-Genetically Modified Neurons

Light can be used to activate normal, non-genetically modified neurons through the use of targeted gold nanoparticles, report scientists from the University of Chicago and the University of Illinois at Chicago. The new technique, described in the journal Neuron on March 12, represents a significant technological advance with potential advantages over current optogenetic methods, including possible use in the development of therapeutics toward diseases such as macular degeneration.

13 Mar 2015

Nanomedicine News

LamdaGen Opens Wholly-Owned Subsidiary, LamdaGen Nanotechnology Taiwan

Global Forecast Report on Nanotechnology in Medical Devices Market

UTHSC CTRC Begins Nanotherapy Brain Cancer Trial in Humans

Nanotherapeutics Secures $28.5 Million Debt Financing from White Oak Global Advisors

Nanotechnologies in Drug Delivery Congress to be Held 27 - 28 April 2015 in London

Immune Licenses Yissum's Patents to Facilitate Development of AmiKet’s Topical Nanoparticle Formulation

N1 Technologies Seeks Patent for Nano Engineered TungstenGlass

Disposable Molecular Ruler Helps Determine Length of Bacteria’s Nanoscopic Needle

New Research into Using Magnetic Nanoparticles in Localised Brain Tissue Stimulation

Light and Targeted Gold Nanoparticles Can Be Used to Activate Non-Genetically Modified Neurons

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting